Opening Hours : Monday to Friday 8.30am to 4.30pm
  Call Us : (07) 3719 5577

Noticeboard & Media

Medical Journal of Australia February 2017 Herbal Medicine Risk

A comprehensive article about the risks of using over the counter herbal medicines with prescription medications. Click on the image to read.

ABC Radio Health Report with Norman Swann:  Re-Embracing Methotrexate


There are a number of misconceptions about the use of anti-rheumatic drug methotrexate in the treatment of rheumatoid arthritis.
The drug is often confused for chemotherapy, as it can be used in combination with other cytotoxic drugs to treat cancer.
But its use in the treatment regime for rheumatoid arthritis differs from cancer in a number of ways – it’s time to clear up the misconceptions!

Click on the image or title to listen to the podcast.



Methotrexate has an image problem Article

Article from Medical Journal Australia

November 2016





Changes To Medicare Rebates

From 1 July 2016, Medicare benefit cheques are stopping. This means patients will need to register their bank account details with Medicare so their benefit can be paid directly into their bank account via EFT. This change was announced in the 2015-16 Federal Budget and Medicare says that this will ensure all claimants have access to their Medicare payments faster.

Claimants can register their bank account details:

ResMed ASV Pump Recall

ResMed have informed us of a serious safety concern regarding their ASV pumps due to an (unpublished) finding that could increase the risk of cardiovascular death with Adaptive Servo-Ventilation (ASV) therapy for cardiac patients with central sleep apnoea.

Only patients using ASV, with significant chronic heart failure and with reduced ejection fraction are at risk.  You may or may not know if this applies to you. ResMed are recommending that patients who fall under these parameters, see their treating physician for review.

If you use one of the following Resmed ASV machines, you will need to contact us at your earliest convenience:

VPAP ADAPT – APAC    AirCurve 10 CS PaceWave ANZ TRI VPAP Tx     S9 VPAP Tx – APAC

ResMed inform us that there has been no malfunction or technical fault with the operation of the device, it operates correctly to treat central sleep apnoea. The identified risk is with the use of ASV in this at-risk population. This issue has not yet been resolved and we await, with interest, the published paper on this study.

For more information



Bird Fanciers Lung Disease

Bird Fanciers Lung Disease


Parrot Society Magazine August 2014

You can listen to Professor Roger Allen in media releases by clicking on the image.

[metaslider id=495]